Trial Outcomes & Findings for Cerebral Autoregulation Monitoring During Cardiac Surgery (NCT NCT00981474)

NCT ID: NCT00981474

Last Updated: 2026-06-05

Results Overview

The composite neurological outcome was composed of clinical stroke, or new ischemic lesions detected on postoperative brain diffusion weighted magnetic resonance imaging(DWI), or cognitive decline from baseline to 4-6 weeks after surgery.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

460 participants

Primary outcome timeframe

Up to 6 weeks post-operative

Results posted on

2026-06-05

Participant Flow

After obtaining written informed consent, 468 were randomized to the two groups. 237 in the autoregulation group were randomized after consent and 5 subjects withdrew consent. 231 in the usual care group were randomized after consent and 3 subjects withdrew consent.

Participant milestones

Participant milestones
Measure
Usual Care Group (Control)
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Overall Study
STARTED
228
232
Overall Study
COMPLETED
228
232
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cerebral Autoregulation Monitoring During Cardiac Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care Group
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Total
n=460 Participants
Total of all reporting groups
Age, Continuous
70.8 years
STANDARD_DEVIATION 8.0 • n=20 Participants
70.0 years
STANDARD_DEVIATION 7.3 • n=20 Participants
70.4 years
STANDARD_DEVIATION 7.6 • n=40 Participants
Sex/Gender, Customized
Female
67 participants
n=20 Participants
62 participants
n=20 Participants
129 participants
n=40 Participants
Sex/Gender, Customized
Male
160 participants
n=20 Participants
170 participants
n=20 Participants
330 participants
n=40 Participants
Sex/Gender, Customized
Missing designation
1 participants
n=20 Participants
0 participants
n=20 Participants
1 participants
n=40 Participants
Race/Ethnicity, Customized
Caucasian
189 participants
n=20 Participants
184 participants
n=20 Participants
273 participants
n=40 Participants
Race/Ethnicity, Customized
African American
24 participants
n=20 Participants
28 participants
n=20 Participants
52 participants
n=40 Participants
Race/Ethnicity, Customized
Hispanic
3 participants
n=20 Participants
2 participants
n=20 Participants
5 participants
n=40 Participants
Race/Ethnicity, Customized
Native American
1 participants
n=20 Participants
3 participants
n=20 Participants
4 participants
n=40 Participants
Race/Ethnicity, Customized
Asian
0 participants
n=20 Participants
4 participants
n=20 Participants
4 participants
n=40 Participants
Race/Ethnicity, Customized
Multiple
0 participants
n=20 Participants
2 participants
n=20 Participants
2 participants
n=40 Participants
Race/Ethnicity, Customized
Other
10 participants
n=20 Participants
9 participants
n=20 Participants
19 participants
n=40 Participants
Region of Enrollment
United States
228 Participants
n=20 Participants
232 Participants
n=20 Participants
460 Participants
n=40 Participants
Highest Grade of Formal Education (median,[inter-quartile range])
14.0 Years
n=20 Participants
14.5 Years
n=20 Participants
14 Years
n=40 Participants
Mini-Mental State Exam
28 score on a scale (30 good- 0 poor)
n=20 Participants
28 score on a scale (30 good- 0 poor)
n=20 Participants
28 score on a scale (30 good- 0 poor)
n=40 Participants
History of a prior stroke
25 Participants
n=20 Participants
19 Participants
n=20 Participants
44 Participants
n=40 Participants
History of hypertension
213 Participants
n=20 Participants
207 Participants
n=20 Participants
420 Participants
n=40 Participants
History of atrial fibrillation
53 Participants
n=20 Participants
49 Participants
n=20 Participants
102 Participants
n=40 Participants
History of myocardial infarction
65 Participants
n=20 Participants
74 Participants
n=20 Participants
139 Participants
n=40 Participants
History of chronic obstructive lung disease
31 Participants
n=20 Participants
21 Participants
n=20 Participants
52 Participants
n=40 Participants
Obstructive sleep apnea
41 Participants
n=20 Participants
36 Participants
n=20 Participants
77 Participants
n=40 Participants
Current tobacco use
22 Participants
n=20 Participants
24 Participants
n=20 Participants
46 Participants
n=40 Participants
History of diabetes
101 Participants
n=20 Participants
108 Participants
n=20 Participants
209 Participants
n=40 Participants
History of anemia
101 Participants
n=20 Participants
108 Participants
n=20 Participants
209 Participants
n=40 Participants
Logistic EuroSCORE (median,[interquartile range])
5.3 score on a scale 0-2 good >=5 high risk
n=20 Participants
5.08 score on a scale 0-2 good >=5 high risk
n=20 Participants
5.19 score on a scale 0-2 good >=5 high risk
n=40 Participants
Cardiopulmonary bypass duration
107 Minutes
n=20 Participants
103 Minutes
n=20 Participants
105 Minutes
n=40 Participants
Type of surgery
Coronary Artery Bypass Graft (CABG)
109 Participants
n=20 Participants
117 Participants
n=20 Participants
226 Participants
n=40 Participants
Type of surgery
Coronary Aertery Bypass Graft, Aortic Valve Replacement (CABG/AVR)
35 Participants
n=20 Participants
26 Participants
n=20 Participants
61 Participants
n=40 Participants
Type of surgery
Coronary Artery Bypass Graft, Mitral Valve Replacement CABG/MVR)
6 Participants
n=20 Participants
9 Participants
n=20 Participants
15 Participants
n=40 Participants
Type of surgery
Coronary Artery Bypass Graft, Aortic Valve Replacement, Mitral Valve Replacement (CABG/AVR/MVR)
3 Participants
n=20 Participants
3 Participants
n=20 Participants
6 Participants
n=40 Participants
Type of surgery
Aortic Valve Replacement (AVR)
41 Participants
n=20 Participants
48 Participants
n=20 Participants
89 Participants
n=40 Participants
Type of surgery
Mitral Valve Replacement (MVR)
19 Participants
n=20 Participants
22 Participants
n=20 Participants
41 Participants
n=40 Participants
Type of surgery
Aortic Valve Replacement, Mitral Valve Replacement (AVR/MVR)
9 Participants
n=20 Participants
5 Participants
n=20 Participants
14 Participants
n=40 Participants
Type of surgery
Aortic Root Replacement
2 Participants
n=20 Participants
2 Participants
n=20 Participants
4 Participants
n=40 Participants
Type of surgery
Coronary Artery Bypass Graft, (CABG) / Aortic Root Replacement
1 Participants
n=20 Participants
0 Participants
n=20 Participants
1 Participants
n=40 Participants
Type of surgery
Transcatheter Aortic Valve Replacement (TAVR)
3 Participants
n=20 Participants
0 Participants
n=20 Participants
3 Participants
n=40 Participants
Aortic cross-clamp (time in minutes)
73 Minutes
n=20 Participants
69 Minutes
n=20 Participants
71 Minutes
n=40 Participants
Duration of ICU admission (hours)
44.1 Hours
n=20 Participants
44 Hours
n=20 Participants
44 Hours
n=40 Participants
Duration of hospitalization (days)
8 Days
n=20 Participants
7 Days
n=20 Participants
7 Days
n=40 Participants

PRIMARY outcome

Timeframe: Up to 6 weeks post-operative

Population: Subjects who completed neurological testing and MRI testing

The composite neurological outcome was composed of clinical stroke, or new ischemic lesions detected on postoperative brain diffusion weighted magnetic resonance imaging(DWI), or cognitive decline from baseline to 4-6 weeks after surgery.

Outcome measures

Outcome measures
Measure
Control
n=101 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=93 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Composite Neurological Outcome of Clinical Stroke or New Ischemic Brain Lesion on Diffusion Weighted MRI or Neurocognitive Dysfunction 4 to 6 Weeks After Surgery.
79 Participants
70 Participants

SECONDARY outcome

Timeframe: Postoperative days 1-4

Population: Delirium was measured day 1-4. 232 in the autoregulation group were assessed and 228 were assessed in the usual care group.

Assessed with Confusion Assessment Method or Confusion Assessment Method-ICU along with adjudication by team of experts

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Postoperative Delirium
34 Participants
19 Participants

SECONDARY outcome

Timeframe: 7 days after surgery

Population: 228 in the usual care group and 232 in the autoregulation group were analyzed.

Use of multiple inotropic drugs greater than 24 hours after the planned surgical procedure until discharge from the hospital.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Multiple Inotropic Drugs>24 Hours After Surgery
13 participants
6 participants

SECONDARY outcome

Timeframe: Up to 28 days after surgery.

Subjects need for mechanical lung ventilation more than 24 hours after planned surgical procedure.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Mechanical Lung Ventilation>24 Hours After Surgery
22 Participants
13 Participants

SECONDARY outcome

Timeframe: 7 days after surgery

Procedural insertion of intra-aortic balloon pump within 7 days after surgical procedure

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Insertion of Intra-aortic Balloon Pump
19 Participants
14 Participants

SECONDARY outcome

Timeframe: Up to 28 days after surgery.

Clinical diagnosis of postoperative atrial fibrillation from date of surgical procedure to discharge from the hospital.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Postoperative Atrial Fibrillation
89 Participants
79 Participants

SECONDARY outcome

Timeframe: Up to 28 days after surgery.

Clinical diagnosis of sepsis from time of surgical procedure to discharge from the hospital.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Sepsis
7 Participants
2 Participants

SECONDARY outcome

Timeframe: 7 days after surgery

Subject developed acute kidney injury within 7 days after surgical procedure. Based on Kidney disease: Improving Global Outcomes (KDIGO) classification system.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Acute Kidney Injury Within 7 Days After Surgery.
56 Participants
62 Participants

SECONDARY outcome

Timeframe: Up to 28 days after surgery.

Subjects requiring new renal replacement therapy prior to discharge from hospital

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
New Renal Replacement Therapy
6 Participants
4 Participants

SECONDARY outcome

Timeframe: Up to 28 days after surgery.

Subject diagnosis of multisystem organ failure after surgery.

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Multisystem Organ Failure After Surgery
7 Participants
2 Participants

SECONDARY outcome

Timeframe: 28 days

Subject death within 28 days after surgical procedure

Outcome measures

Outcome measures
Measure
Control
n=228 Participants
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 Participants
Blood pressure management based on cerebral autoregulation data. blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Mortality
12 Participants
5 Participants

Adverse Events

Usual Care Group (Control)

Serious events: 133 serious events
Other events: 34 other events
Deaths: 12 deaths

Autoregulation Group

Serious events: 121 serious events
Other events: 19 other events
Deaths: 5 deaths

Serious adverse events

Serious adverse events
Measure
Usual Care Group (Control)
n=228 participants at risk
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 participants at risk
Blood pressure management based on cerebral autoregulation data. Blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Renal and urinary disorders
Acute Kidney Injury
24.6%
56/228 • Number of events 56 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
26.7%
62/232 • Number of events 62 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
General disorders
Multisystem Organ Failure after Surgery
2.6%
6/228 • Number of events 6 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
1.7%
4/232 • Number of events 4 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
Blood and lymphatic system disorders
Sepsis
3.1%
7/228 • Number of events 7 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
0.86%
2/232 • Number of events 2 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
Nervous system disorders
Clinical Stroke
3.9%
9/228 • Number of events 9 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
5.6%
13/232 • Number of events 13 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
Nervous system disorders
New Ischemic Lesions in Brian
55.3%
47/85 • Number of events 47 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
60.8%
48/79 • Number of events 48 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
General disorders
Delayed Neurocognitive Recovery
21.3%
35/164 • Number of events 35 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
15.7%
27/172 • Number of events 27 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.

Other adverse events

Other adverse events
Measure
Usual Care Group (Control)
n=228 participants at risk
Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management. Control group: Institutional standard of care.
Autoregulation Group
n=232 participants at risk
Blood pressure management based on cerebral autoregulation data. Blood pressure maintenance based on cerebral blood flow autoregulation measurement: Blood pressure lowered or raised
Psychiatric disorders
Clinically detected delirium
14.9%
34/228 • Number of events 34 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.
8.2%
19/232 • Number of events 19 • Data were collected over a period of 1 year.
Postoperative complications were based on the Society of Thoracic Surgery National Cardiac Surgery Database definitions (www.sts.org) as safety outcomes.

Additional Information

Paul C. Fitzgerald RN, BSN, MS

Northwestern University

Phone: 312-695-1064

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place